Loading insider details...
Beta
Latest Form 4 (Jul 30, 2026): Grant/Award of 221,667 VKTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 30, 2026 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 221,667 | n/a |
| Jan 6, 2026 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 78,400 | n/a |
| Oct 28, 2025 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 70,084 | n/a |
| Jul 3, 2025 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 48,333 | n/a |
| Jan 7, 2025 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 92,800 | n/a |
| Sep 21, 2024 | Viking Therapeutics, Inc. (VKTX) | Exercise/Conversion | 166,130 | $1.29M |
| Aug 22, 2024 | Viking Therapeutics, Inc. (VKTX) | Exercise/Conversion | 1,000 | $7.8K |
| Aug 20, 2024 | Viking Therapeutics, Inc. (VKTX) | Exercise/Conversion | 112,870 | $877.0K |
| Jul 31, 2024 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 41,000 | n/a |
| Mar 28, 2024 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 221,667 | n/a |